Should MMF treatment be the first-line therapy in autoimmune hepatitis?

Laurent Alric¹

Affiliations

Affiliation

¹ Internal Medicine- Department of Gastroenterology and Hepatology, Rangueil Hospital, Toulouse 3 University, Toulouse, France. Electronic address: alric.l@chu-toulouse.fr.

PMID: 38403032
DOI: 10.1016/j.jhep.2024.02.014

Comment

Should MMF treatment be the first-line therapy in autoimmune hepatitis?

Laurent Alric. J Hepatol. 2024 Jul.

. 2024 Jul;81(1):e40.

doi: 10.1016/j.jhep.2024.02.014. Epub 2024 Feb 23.

Author

Laurent Alric¹

Affiliation

¹ Internal Medicine- Department of Gastroenterology and Hepatology, Rangueil Hospital, Toulouse 3 University, Toulouse, France. Electronic address: alric.l@chu-toulouse.fr.

PMID: 38403032
DOI: 10.1016/j.jhep.2024.02.014

No abstract available

PubMed Disclaimer

Comment in

Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".
Snijders RJALM, Stoelinga AEC, van Hoek B, Drenth JPH. Snijders RJALM, et al. J Hepatol. 2024 Jul;81(1):e43-e44. doi: 10.1016/j.jhep.2024.03.038. Epub 2024 Mar 28. J Hepatol. 2024. PMID: 38554845 No abstract available.

Comment on

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.
Snijders RJALM, Stoelinga AEC, Gevers TJG, Pape S, Biewenga M, Tushuizen ME, Verdonk RC, de Jonge HJM, Vrolijk JM, Bakker SF, Vanwolleghem T, de Boer YS, Baven Pronk MAMC, Beuers U, van der Meer AJ, Gerven NMFV, Sijtsma MGM, van Eijck BC, van IJzendoorn MC, van Herwaarden M, van den Brand FF, Korkmaz KS, van den Berg AP, Guichelaar MMJ, Levens AD, van Hoek B, Drenth JPH; Dutch Autoimmune Hepatitis Working Group. Snijders RJALM, et al. J Hepatol. 2024 Apr;80(4):576-585. doi: 10.1016/j.jhep.2023.11.032. Epub 2023 Dec 14. J Hepatol. 2024. PMID: 38101756 Clinical Trial.

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Should MMF treatment be the first-line therapy in autoimmune hepatitis?

Affiliation

Should MMF treatment be the first-line therapy in autoimmune hepatitis?

Author

Affiliation

Comment in

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources